SEARCH

SEARCH BY CITATION

References

  • 1
    Selman PJ, Mol JA, Rutteman GR, et al. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 1994;134:287292.
  • 2
    Selman PJ, Mol JA, Rutteman GR, Rijnberk A. Progestin treatment in the dog. I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis. Eur J Endocrinol 1994;131:413421.
  • 3
    Eigenmann JE, Eigenmann RY, Rijnberk A, et al. Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol 1983;104:167176.
  • 4
    Kopchick JJ. Growth and maturation. In: Melmed S, ed. Endocrinology. Philadelphia, PA: W.B. Saunders; 2001:389404.
  • 5
    Pierluissi J, Campbell J. Metasomatotrophic diabetes and its induction: Basal insulin secretion and insulin release responses to glucose, glucagon, arginine and meals. Diabetologia 1980;18:223228.
  • 6
    Clayton PE, Banerjee I, Murray PG, Renehan AG. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 2011;7:1124.
  • 7
    Queiroga FL, Perez-Alenza MD, Silvan G, et al. Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours. J Steroid Biochem Mol Biol 2008;110:7682.
  • 8
    Pérez Alenza MD, Tabanera E, Peña L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J Am Vet Med Assoc 2001;219:11101114.
  • 9
    Queiroga FL, Perez-Alenza D, Silvan G, et al. Serum and intratumoural GH and IGF-I concentrations: Prognostic factors in the outcome of canine mammary cancer. Res Vet Sci 2010;89:396403.
  • 10
    Fall T, Hamlin HH, Hedhammar A, et al. Diabetes mellitus in a population of 180,000 insured dogs: Incidence, survival, and breed distribution. J Vet Intern Med 2007;21:12091216.
  • 11
    Fall T, Hedhammar A, Wallberg A, et al. Diabetes mellitus in Elkhounds is associated with diestrus and pregnancy. J Vet Intern Med 2010;24:13221328.
  • 12
    Mared M, Catchpole B, Kampe O, Fall T. Evaluation of circulating concentrations of glucose homeostasis biomarkers, progesterone, and growth hormone in healthy Elkhounds during anestrus and diestrus. Am J Vet Res 2012;73:242247.
  • 13
    Beijerink NJ, Bhatti SFM, Okkens AC, et al. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate. Domest Anim Endocrinol 2007;32:6378.
  • 14
    Mohan S, Baylink DJ. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: Comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 1995;80:637647.
  • 15
    Smith LF. Species variation in the amino acid sequence of insulin. Am J Med 1966;40:662666.
  • 16
    Fall T, Holm B, Karlsson A, et al. Glucagon stimulation test for estimating endogenous insulin secretion in dogs. Vet Rec 2008;163:266270.
  • 17
    Fall T. Characterisation of Diabetes Mellitus in Dogs. Doctoral Thesis. Uppsala: Swedish University of Agricultural Sciences; 2009.
  • 18
    Kutzler MA, Mohammed HO, Lamb SV, et al. Accuracy of canine parturition date prediction from the initial rise in preovulatory progesterone concentration. Theriogenology 2003;60:11871196.
  • 19
    Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:21912192.
  • 20
    Royston P, White IR. Multiple imputation by chained equations (MICE): Implementation in Stata. J Stat Softw 2011;45:120.
  • 21
    Eigenmann JE, Becker M, Kammermann B, et al. Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy. Acta Endocrinol 1977;85:818822.
  • 22
    Wada T, Hori S, Sugiyama M, et al. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2010;298:E881E888.
  • 23
    Prahalada S, Stabinski LG, Chen HY, et al. Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs. Toxicol Pathol 1998;26:185200.
  • 24
    Batista MR, Smith MS, Snead WL, et al. Chronic estradiol and progesterone treatment in conscious dogs: Effects on insulin sensitivity and response to hypoglycemia. Am J Physiol Regul Integr Comp Physiol 2005;289:R1064R1073.
  • 25
    Eigenmann JE, Rijnberk A. Influence of medroxyprogesterone acetate (Provera) on plasma growth hormone levels and on carbohydrate metabolism. I. Studies in the ovariohysterectomised bitch. Acta Endocrinol 1981;98:599602.
  • 26
    Kooistra HS, Okkens AC. Secretion of prolactin and growth hormone in relation to ovarian activity in the dog. Reprod Domest Anim 2001;36:115119.
  • 27
    Gayet C, Bailhache E, Dumon H, et al. Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity. J Anim Physiol Anim Nutr (Berl) 2004;88:157165.
  • 28
    Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: The role of the insulin–IGF axis. Trends Endocrinol Metab 2006;17:328336.
  • 29
    Baxter RC, Bryson JM, Turtle JR. Somatogenic receptors of rat liver: Regulation by insulin. Endocrinology 1980;107:11761181.
  • 30
    Leung KC, Doyle N, Ballesteros M, et al. Insulin regulation of human hepatic growth hormone receptors: Divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab 2000;85:47124720.
  • 31
    Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579591.
  • 32
    Verkest KR, Fleeman LM, Rand JS, et al. Basal measures of insulin sensitivity and insulin secretion and simplified glucose tolerance tests in dogs. Domest Anim Endocrinol 2010;39:194204.
  • 33
    Polonsky KS, Pugh W, Jaspan JB, et al. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J Clin Investig 1984;74:18211829.
  • 34
    Arcidiacono B, Iiritano S, Nocera A, et al. Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms. Exp Diabetes Res 2012;2012:789174.
  • 35
    Eigenmann JE, Patterson DF, Zapf J, Froesch ER. Insulin-like growth factor I in the dog: A study in different dog breeds and in dogs with growth hormone elevation. Acta Endocrinol 1984;105:294301.
  • 36
    Sutter NB, Bustamante CD, Chase K, et al. A single IGF1 allele is a major determinant of small size in dogs. Science (New York, NY) 2007;316:112115.
  • 37
    Yamka RM, Friesen KG, Frantz NZ. Identification of canine markers related to obesity and the effects of weight loss on the markers of interest. Intern J Appl Res Vet Med 2006;4:282292.
  • 38
    Martin LJ, Siliart B, Dumon HJ, Nguyen PG. Hormonal disturbances associated with obesity in dogs. J Anim Physiol Anim Nutr (Berl) 2006;90:355360.
  • 39
    Greer KA, Hughes LM, Masternak MM. Connecting serum IGF-1, body size, and age in the domestic dog. Age 2011;33:475483.
  • 40
    Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14:2039.
  • 41
    Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 2012;41:425443.
  • 42
    Mol JA, Van Garderen E, Selman PJ, et al. Growth hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 1995;95:20282034.
  • 43
    Rutteman GR, Misdorp W, Van den Brom WE, Rijnberk A. Anterior pituitary function in female dogs with spontaneous mammary tumors: I. Growth hormone. Anticancer Res 1989;9:235239.
  • 44
    Hellmén E, Bergström R, Holmberg L, et al. Prognostic factors in canine mammary tumors: A multivariate study of 202 consecutive cases. Vet Pathol 1993;30:2027.
  • 45
    Matos AJF, Baptista CS, Gärtner MF, Rutteman GR. Prognostic studies of canine and feline mammary tumours: The need for standardized procedures. Vet J 2012;193:2431.